WASHINGTON AP - Allergan Inc., the maker of wrinkle-smoothing Botox, says it will pay $600 million to settle a five-year-long federal investigation into its marketing of the top-selling, botulin-based drug.The company said Wednesday in a statement it will plead guilty to one misdemeanor charge of "misbranding," in which the company's marketing led physicians to use Botox for unapproved uses.
September 01, 2010 at 12:00 AM
1 minute read
WASHINGTON AP – Allergan Inc., the maker of wrinkle-smoothing Botox, says it will pay $600 million to settle a five-year-long federal investigation into its marketing of the top-selling, botulin-based drug.
The company said Wednesday in a statement it will plead guilty to one misdemeanor charge of “misbranding,” in which the company’s marketing led physicians to use Botox for unapproved uses. Those included the treatment of headache, pain, spasticity and cerebral palsy in children.
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
Description: Fox Rothschild has an opening in the New York office for a Real Estate Litigation Associate with three to six years of commerci...
Downtown NY property and casualty defense law firm seeks a Litigation Associate with 3+ years' experience to become a part of our team! You ...
Description: Fox Rothschild has an opening in the New York office for a Counsel in our renowned Labor & Employment Department, working w...
